This article is currently undergoing investigation.
Research Paper Volume 13, Issue 1 pp 411—423
The improved anticancer effects of Bortezomib-loaded hollow mesoporous silica nanospheres on lymphoma development
Figure 7. Schematic illustration of the loading and delivery and release of BTZ to the cancer cells by HMSNs.